Solara Active Pharma Sciences

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue401.61100.34360.82330.07338.37
Expenses358.21227.14376.42345.65339.43
EBITDA43.40-126.80-15.60-15.58-1.06
EBIT15.02-155.24-43.42-43.71-29.69
Profit Before Tax29.68-139.89-31.00-31.10-19.30
Net Profit29.71-139.871.88-16.43-9.96
Financial Ratios
Operating Profit Margin10.81%-126.37%-4.32%-4.72%-0.31%
Net Profit Margin7.40%-139.40%0.52%-4.98%-2.94%
Earning Per Share (Diluted)8.24-38.510.76-4.56-2.77
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI